Non-Euclidean geometry

AvantGuard Applauded by Frost & Sullivan for Extending the Life of Chlorine-based Disinfectants for Sustained Efficacy with Its Residual Antimicrobial Solutions

Retrieved on:

Mardi, mai 2, 2023

Pollution, Food, F&B, Silver, Research, Noetics, Zwitterion, Auburn University, Disinfectant, Hospital, SAN, AvantGuard, Chlorine, Water, Non-Euclidean geometry, Antibiotics, Copper, Sewage treatment

SAN ANTONIO, May 2, 2023 /PRNewswire/ -- Frost & Sullivan recently assessed the North American residual antimicrobials industry and, based on its findings, recognizes AvantGuard with the 2023 North American Technology Innovation Leadership Award for its residual antimicrobial solutions. The company adopts automated disinfection protocols to minimize manual labor and ensure wide-scale uniform cleaning in the residential, commercial, and industrial sectors. AvantGuard partnered with Auburn University in 2019 to license the N-halamine technology and develop residual antimicrobials to provide prolonged efficacy and to meet the global demand for the same. The company integrates the N-halamine and zwitterion structure to fabricate a lineup of durable antimicrobial solutions that provide sustained antimicrobial efficacy.

Key Points:

SAN ANTONIO, May 2, 2023 /PRNewswire/ -- Frost & Sullivan recently assessed the North American residual antimicrobials industry and, based on its findings, recognizes AvantGuard with the 2023 North American Technology Innovation Leadership Award for its residual antimicrobial solutions.
The company integrates the N-halamine and zwitterion structure to fabricate a lineup of durable antimicrobial solutions that provide sustained antimicrobial efficacy.
AvantGuard's AvantGuard247™ and 1stAid™ provide safe and long-lasting alternatives for residual disinfectant applications, such as conventional copper-based antimicrobial technology.
With its impressive overall performance, AvantGuard, Inc. earns Frost & Sullivan's 2022 Technology Innovation Leadership Award in the North American residual antimicrobial industry.

AvantGuard Applauded by Frost & Sullivan for Extending the Life of Chlorine-based Disinfectants for Sustained Efficacy with Its Residual Antimicrobial Solutions

Retrieved on:

Mardi, mai 2, 2023

Pollution, Food, F&B, Silver, Research, Noetics, Zwitterion, Auburn University, Disinfectant, Hospital, SAN, AvantGuard, Chlorine, Water, Non-Euclidean geometry, Antibiotics, Copper, Sewage treatment

SAN ANTONIO, May 2, 2023 /PRNewswire/ -- Frost & Sullivan recently assessed the North American residual antimicrobials industry and, based on its findings, recognizes AvantGuard with the 2023 North American Technology Innovation Leadership Award for its residual antimicrobial solutions. The company adopts automated disinfection protocols to minimize manual labor and ensure wide-scale uniform cleaning in the residential, commercial, and industrial sectors. AvantGuard partnered with Auburn University in 2019 to license the N-halamine technology and develop residual antimicrobials to provide prolonged efficacy and to meet the global demand for the same. The company integrates the N-halamine and zwitterion structure to fabricate a lineup of durable antimicrobial solutions that provide sustained antimicrobial efficacy.

Key Points:

SAN ANTONIO, May 2, 2023 /PRNewswire/ -- Frost & Sullivan recently assessed the North American residual antimicrobials industry and, based on its findings, recognizes AvantGuard with the 2023 North American Technology Innovation Leadership Award for its residual antimicrobial solutions.
The company integrates the N-halamine and zwitterion structure to fabricate a lineup of durable antimicrobial solutions that provide sustained antimicrobial efficacy.
AvantGuard's AvantGuard247™ and 1stAid™ provide safe and long-lasting alternatives for residual disinfectant applications, such as conventional copper-based antimicrobial technology.
With its impressive overall performance, AvantGuard, Inc. earns Frost & Sullivan's 2022 Technology Innovation Leadership Award in the North American residual antimicrobial industry.

QuantumFP: Accelerating Drug Discovery with Quantum Fingerprinting

Retrieved on:

Vendredi, mars 31, 2023

Non-Euclidean geometry, Drug discovery, Cloud computing, AI, Quantum, Research, Safety, Collection, Risk, Fingerprint, Drug design, Pharmaceutical industry

BOSTON, March 31, 2023 /PRNewswire-PRWeb/ -- Quantum Simulation Technologies, Inc. (QSimulate) announces the launch of QuantumFP (Quantum FingerPrinting) in QSP Life, which enables automated high-throughput simulation of quantum mechanical fingerprints of drug-like molecules for data-driven discovery. This new product addresses the growing need for more precise, reliable, and cost-effective molecular data in modern drug discovery.

Key Points:

QSimulate launches a high-throughput quantum fingerprinting product for drug-like molecules, adding a novel dimension to data-driven discovery.
BOSTON, March 31, 2023 /PRNewswire-PRWeb/ -- Quantum Simulation Technologies, Inc. (QSimulate) announces the launch of QuantumFP (Quantum FingerPrinting) in QSP Life, which enables automated high-throughput simulation of quantum mechanical fingerprints of drug-like molecules for data-driven discovery.
This new product addresses the growing need for more precise, reliable, and cost-effective molecular data in modern drug discovery.
Quantum fingerprints are expected to play an important role in data-driven drug discovery because small changes in molecular structure can have significant impacts on efficacy and safety.

Ethos Asset Management Inc., USA, Announces Deal with GreenGlycols® Green Glycols B.V., to Develop a BioMPG Production Facility in The Netherlands

Retrieved on:

Mercredi, mars 29, 2023

Ethos, Partnership, GBE, Propylene glycol, Cosmetics, Associate, Chemistry, Chemical industry, SAN, MPG, Non-Euclidean geometry, Growth, Environment, Diol, Renewable energy

SAN DIEGO, March 29, 2023 /PRNewswire/ -- ETHOS ASSET MANAGEMENT INC USA, announced a new long-term financing partnership with GreenGlycols® Green Glycols B.V., a 50/50 Joint Venture between ChemCom Dunaliella B.V. and GBE Europe B.V. Ethos has committed to providing significant capital infusion that will continue for several years.

Key Points:

Partnership Provides Long Term Financing to GreenGlycols® to build a BioMPG production facility with an annual production capacity of 40,000 tonnes in Delfzijl, the Netherlands.
Carlos Santos, CEO of Ethos Asset Management Inc, stated,
"We are very pleased to announce this impactful and sustainable project to produce Mono Propylene Glycol (MPG).
In the sustainable process of Green Glycols, traditional petrochemical raw materials for MPG are replaced by vegetable glycerine.
We are proud to work together with Grupo Bahia Energia and Ethos Asset Management Inc. as partners to make the GreenGlycols® concept a reality.

Researchers Discover How Too Much Oxygen Damages Cells and Tissues

Retrieved on:

Mercredi, mars 8, 2023

SAN FRANCISCO, March 8, 2023 /PRNewswire/ -- When it comes to oxygen, you can have too much of a good thing. Breathing air that contains higher levels of oxygen than the usual 21 percent found in Earth's atmosphere can cause organ damage, seizures, and even death in people and animals, particularly if it's in excess of the body's oxygen needs. Until now, however, scientists have mostly speculated about the mechanisms behind this phenomenon, known as oxygen toxicity, or hyperoxia.

Key Points:

Now, researchers at Gladstone Institutes have discovered how excess oxygen changes a handful of proteins in our cells that contain iron and sulfur—a chemical process similar to the rusting of iron.
While clinicians have long studied the details of how oxygen shortage impacts cells and tissues (for example, in heart attacks and strokes), the effects of excess oxygen have been relatively understudied.
As a result, cells stop functioning correctly and consume even less oxygen, causing a further increase in oxygen levels in the surrounding tissues.
"One important takeaway is that hyperoxia is not impacting cells and tissues solely through reactive oxygen species, as many had assumed," says Jain.

Kanazawa University research: Locking and unlocking molecular structures on demand

Retrieved on:

Lundi, février 27, 2023

Solvent, Carbon, Angewandte Chemie, Rotation, Kanazawa University, Palladium, Bromine, Caesium, Distortion, Chem, Rotaxane, Human, Non-Euclidean geometry, Noetics, Light, Phosphorus

KANAZAWA, Japan, Feb. 27, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Angewandte Chemie International Edition how the formation and deformation speed of interlocked molecular structures called rotaxanes can be tuned — a discovery that may lead to an enhanced functionality of rotaxanes as building blocks for molecular machines.

Key Points:

KANAZAWA, Japan, Feb. 27, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Angewandte Chemie International Edition how the formation and deformation speed of interlocked molecular structures called rotaxanes can be tuned — a discovery that may lead to an enhanced functionality of rotaxanes as building blocks for molecular machines.
Rotaxanes are molecules with a two-component structure: a dumbbell-shaped part (the 'axle') threaded through a ring-like part (the 'wheel').
Shigehisa Akine, Yoko Sakata, and colleagues from Kanazawa University have now developed a new approach for controlled rotaxane dissociation and formation.
Shigehisa Akine, Yoko Sakata, and colleagues from Kanazawa University have now studied the formation and dissociation process of a palladium-containing rotaxane.

Kanazawa University research: Locking and unlocking molecular structures on demand

Retrieved on:

Lundi, février 27, 2023

Solvent, Carbon, Angewandte Chemie, Rotation, Kanazawa University, Palladium, Bromine, Caesium, Distortion, Chem, Rotaxane, Human, Non-Euclidean geometry, Noetics, Light, Phosphorus

KANAZAWA, Japan, Feb. 27, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Angewandte Chemie International Edition how the formation and deformation speed of interlocked molecular structures called rotaxanes can be tuned — a discovery that may lead to an enhanced functionality of rotaxanes as building blocks for molecular machines.

Key Points:

KANAZAWA, Japan, Feb. 27, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Angewandte Chemie International Edition how the formation and deformation speed of interlocked molecular structures called rotaxanes can be tuned — a discovery that may lead to an enhanced functionality of rotaxanes as building blocks for molecular machines.
Rotaxanes are molecules with a two-component structure: a dumbbell-shaped part (the 'axle') threaded through a ring-like part (the 'wheel').
Shigehisa Akine, Yoko Sakata, and colleagues from Kanazawa University have now developed a new approach for controlled rotaxane dissociation and formation.
Shigehisa Akine, Yoko Sakata, and colleagues from Kanazawa University have now studied the formation and dissociation process of a palladium-containing rotaxane.

Insilico Medicine Announces IND Approval of Oral 3CLpro Inhibitor ISM3312 for COVID-19

Retrieved on:

Jeudi, février 23, 2023

ISM3312 is a highly selective 3CLpro inhibitor with a novel molecular structure optimized from compounds designed by Chemistry42, Insilico’s generative chemistry AI platform.

Key Points:

ISM3312 is a highly selective 3CLpro inhibitor with a novel molecular structure optimized from compounds designed by Chemistry42, Insilico’s generative chemistry AI platform.
ISM3312 has a novel molecular structure that provides broad anti-coronavirus activity, excellent single agent oral bioavailability, and potential drug-resistant mutations.
Insilico Medicine, a clinical-stage biotech company powered by generative AI, today announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for ISM3312, an orally available 3CLpro inhibitor generated and designed with the support of Insilico’s proprietary generative chemistry platform Chemistry42 for the treatment of COVID-19.
“Generative AI is transforming every area of human development,” says Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine.

In-line UV-vis Spectroscopy Market Size, Share & Trends Analysis Report 2022: Pharmaceutical/Chemical - Global Forecast to 2030 - ResearchAndMarkets.com

Retrieved on:

Vendredi, janvier 20, 2023

The "In-line UV-vis Spectroscopy Market Size, Share & Trends Analysis Report by Application (Color Measurement, Chemical Concentration), by End-user (Pharmaceutical Industry, Chemical Industry), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "In-line UV-vis Spectroscopy Market Size, Share & Trends Analysis Report by Application (Color Measurement, Chemical Concentration), by End-user (Pharmaceutical Industry, Chemical Industry), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
UV/Visible spectrophotometers are widely used by laboratories, including that associated with academia and governments, as well as other industries.
Thus, accurate calibration of the wavelength axis is important for applications that rely on spectroscopic techniques for compound testing, to receive regulatory approval.
These factors have driven the use of other spectroscopy methods, thereby limiting the revenue growth in this industry.

Main Line Health researcher releases world's first complete resource on molecular structure of virus that causes COVID-19

Retrieved on:

Jeudi, février 16, 2023

Vaccine, SARS-CoV-2, Protein, Lankenau Institute for Medical Research, Genetic code, Molecular biology, Literature, Sunil Thomas, Second Edition, Main Line Health, Medical research, Map, Non-Euclidean geometry, Disease, Infection, Multimedia, Viral, COVID-19, Doctor of Philosophy

WYNNEWOOD, Pa. , Feb. 16, 2023 /PRNewswire/ -- A biomedical researcher at the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, has created a groundbreaking resource for scientists seeking to develop new and better vaccines in the fight against COVID-19.

Key Points:

We will continue to need new vaccines and therapies that are safe and more effective than those available today."
But all the vaccines created targeted the viral spike protein, the part of the virus that binds to human cells.
"Dr. Thomas's efforts to scour the literature and create this open-source compilation of the SARS-CoV-2 molecular structure is an excellent contribution to the scientific community.
The set has reached 120,000 downloads since its January 2022 publication in Springer's Methods in Molecular Biology series.